Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer

E Toska - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Abstract Estrogen receptor-positive (ER+) breast cancer is the most frequent breast cancer
subtype. Agents targeting the ER signaling pathway have been successful in reducing …

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis

A Llorente, MT Blasco, I Espuny, M Guiu, C Ballaré… - Nature Cell …, 2023 - nature.com
MAF amplification increases the risk of breast cancer (BCa) metastasis through mechanisms
that are still poorly understood yet have important clinical implications. Oestrogen-receptor …

The scaffolding function of LSD1 controls DNA methylation in mouse ESCs

S Malla, K Kumari, CA García-Prieto, J Caroli… - Nature …, 2024 - nature.com
Lysine-specific histone demethylase 1 (LSD1), which demethylates mono-or di-methylated
histone H3 on lysine 4 (H3K4me1/2), is essential for early embryogenesis and development …

Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma

LD Caeiro, Y Nakata, RL Borges, M Zha… - Genes & …, 2024 - genesdev.cshlp.org
Approximately 20% of head and neck squamous cell carcinomas (HNSCCs) exhibit reduced
methylation on lysine 36 of histone H3 (H3K36me) due to mutations in histone methylase …

Enhanced desmosome assembly driven by acquired high-level desmoglein-2 promotes phenotypic plasticity and endocrine resistance in ER+ breast cancer

B Liu, Y Liu, S Yang, J Ye, J Hu, S Chen, S Wu, Q Liu… - Cancer Letters, 2024 - Elsevier
Acquired resistance to endocrine treatments remains a major clinical challenge. In this
study, we found that desmoglein-2 (DSG2) plays a major role in acquired endocrine …

Advancing breast cancer diagnosis with a near-infrared fluorescence imaging smart sensor for estrogen/progesterone receptor detection

G Zhang, M Dong, X Yao, Y Xia, H Yu, Y Zhou… - Scientific Reports, 2023 - nature.com
Molecular-genetic imaging has greatly advanced clinical diagnosis and prognosis
monitoring. However, the specific visualization of intracellular proteins such as estrogen …

Relationship between histone demethylase LSD family and development and prognosis of gastric cancer

L Dong, J Zhu, A Deng, J Wei, J Li, X Mao… - Frontiers in …, 2023 - frontiersin.org
Objective to elucidate the correlation between histone demethylase and gastric cancer
Research object histone demethylase and gastric cancer Results As one of the important …

Comprehensive analysis of REST corepressors (RCORs) in pan-cancer

R Zheng, Y Pan, X Liu, F Liu, A Li, D Zheng… - Frontiers in Cell and …, 2023 - frontiersin.org
REST corepressors (RCOR s) are the core component of the LSD1/CoREST/HDACs
transcriptional repressor complex, which have been revealed differently expressed in …

Histone deacetylases and other epigenetic targets

F Carta - Metalloenzymes, 2024 - Elsevier
In mammals, the histone deacetylase enzymes (HDACs: EC 3.5. 1.98) do catalyze the
cleavage of acetyl-lysine residues on proteins of structural and epigenetic meaning and thus …

[HTML][HTML] RCOR1 is targeted by miR-23b-3p to modulate growth, colony formation, migration, and invasion of prostate cancer cells

C Liu, Z Dong, M Li, G Bai, Z Zhao - International Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Objectives: Prostate cancer holds the second-highest incidence rate among all male
malignancies, with a noticeable scarcity of effective treatment approaches. The REST …